REMODULIN DIN 02246554
Status: Marketed
Holder: UNITED THERAPEUTICS CORPORATION
Molecule: TREPROSTINIL (TREPROSTINIL SODIUM)
Available to quote
Health Canada record
| Active ingredient(s) | TREPROSTINIL (TREPROSTINIL SODIUM) 5 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B01AC21 TREPROSTINIL |
| Original market date | 30-Apr-2004 |
| Current status date | 07-Oct-2005 |
| Source | Health Canada DPD |
Establishment licence of the holder
United Therapeutics Corporation — licence , not currently licensed, last inspection rating C (2025-04-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TREPROSTINIL (TREPROSTINIL SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02246552 | REMODULIN | UNITED THERAPEUTICS CORPORATION | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 1 MG | Marketed |
| 02246553 | REMODULIN | UNITED THERAPEUTICS CORPORATION | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 2.5 MG | Marketed |
| 02246555 | REMODULIN | UNITED THERAPEUTICS CORPORATION | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 10 MG | Marketed |
| 02523841 | TREPROSTINIL INJECTION | DR REDDY'S LABORATORIES LTD | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 1 MG | Approved |
| 02523868 | TREPROSTINIL INJECTION | DR REDDY'S LABORATORIES LTD | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 2.5 MG | Approved |
| 02523876 | TREPROSTINIL INJECTION | DR REDDY'S LABORATORIES LTD | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 5 MG | Approved |
| 02523884 | TREPROSTINIL INJECTION | DR REDDY'S LABORATORIES LTD | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 10 MG | Approved |
| 02561700 | TREPROSTINIL INJECTION | MARCAN PHARMACEUTICALS INC | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 1 MG | Approved |
| 02561719 | TREPROSTINIL INJECTION | MARCAN PHARMACEUTICALS INC | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 2.5 MG | Approved |
| 02561727 | TREPROSTINIL INJECTION | MARCAN PHARMACEUTICALS INC | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 5 MG | Approved |
| 02561735 | TREPROSTINIL INJECTION | MARCAN PHARMACEUTICALS INC | Solution | TREPROSTINIL (TREPROSTINIL SODIUM) 10 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 7533 | 2005-10-06 | Supplement to a New Drug Submission (SNDS) | NEW ROUTE OF ADMINISTRATION - INTRAVENOUS |
| 833 | 2002-10-04 | New Drug Submission (NDS) |